Updated:
Evolvient Capital
Evolvient Capital builds leadership teams that tackle real world needs. It ensures the right ingredients are in place for leadership teams to evolve and their...
Evolvient Capital
Evolvient Capital builds leadership teams that tackle real world needs. It ensures the right ingredients are in place for leadership teams to evolve and their businesses to grow, working with start-ups to scale-ups. The firm deploys both experience and capital to build teams and businesses that go further, faster, in a high-support, high-challenge environment. It believes the best businesses are purpose-led and make a positive difference to people's lives and their world.
General information
Firm type
Private Equity
Year founded
2022
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
1 Poultry, London, EC2R 8EJ, United Kingdom
Principals
Ian Temple
Managing Partner
John Hunter
Managing Partner
Frequently asked questions
Who runs investment decisions at Evolvient Capital?
Managing Partners Ian Temple and John Hunter jointly run the firm. Temple previously built and sold recruitment business Hydrogen Group, while Hunter co-founded Argyll Scott and later merged it into Hydrogen. Their biographies, sourced from the firm's own website, describe a partnership with no additional investment committee or external advisors disclosed.
What investment stages does Evolvient Capital target?
The firm states it works from 'start-ups to scale-ups,' but its three named portfolio holdings — Tempting Ventures, Project Partners, and Strategio — were all early-stage ventures at the time of backing. Evolvient does not publish minimum or maximum check sizes, making it impossible to confirm whether it participates in later growth rounds beyond its initial seed- and Series A-stage posture.
Which sectors does Evolvient Capital explicitly avoid?
Evolvient does not maintain a public exclusion list. Its mandate is described simply as 'purpose-led' businesses that solve real-world needs. Without a sector-specific investment policy or compliance disclosure, no formal negative screen — such as restrictions on defense, extractive industries, or predatory lending — is available to an allocator evaluating the firm.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: